the therapeutic effects produced by formulations of amoxicillin plus clavulanic acid ( brl 25 000a and brl 25 000g ) were compared with those of amoxicillin and clavulanic acid separately against a variety of infections produced by amoxicillin-susceptible and beta-lactamase-producing ( amoxicillin-resistant ) bacteria .
C0597979
beta-lactamase
C0004611
bacteria